Vice-President Immunology Discovery & External innovation
Janssen Pharmaceuticals
San Diego, California, United States
Short Bio for Jennifer E. Towne, PhD
Vice President Immunology Discovery
Janssen Research & Development, LLC
Dr. Towne completed her doctoral degree in the Department of Molecular Genetics, Biochemistry, and Microbiology at the University of Cincinnati School of Medicine where she studied the role of aquaporins in pulmonary inflammation and edema. She subsequently joined Immunex as a post-doctoral fellow investigating the role of novel IL-1 family members in physiology and pathophysiology. Dr. Towne was hired at Immunex as a full time scientist and worked at Immunex/Amgen for 13 years focusing on the biology of IL-1 family members, primarily IL-36, IL-17 family members, and IL-23 in the skin, lung and gut. She led or was a key contributor to multiple large and small molecule project teams currently in clinical development for psoriasis and inflammatory bowel disease (IBD). For the last several years she was at Amgen she was responsible for developing the strategy and leading the IBD discovery team. Dr. Towne started at Janssen in November 2014 as Scientific Director, Immunology Discovery, where she was responsible for the IBD discovery efforts. In 2019 she assumed management of the Immunology Discovery group across disease areas and is currently the Vice President of Discovery and External Innovation, Immunology, where her she applies her scientific expertise and insights to lead a group of talented scientists focused on generating an industry-leading Discovery and Early Development Immunology portfolio to transform the treatment of Gastroenterology, Immunodermatology, Rheumatology and Autoimmune diseases.
Disclosure information not submitted.
Friday, June 24, 2022
10:30 AM – 10:55 AM PT
